Pinnacle Medicines (Series B)
Funding Details
Awarder
RSS - www.startupfundingnews.com
Date Award
March 29, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$89,000,000
Company Info
Market
Immunology and Cardiometabolic Diseases
Coinvestors
LAV, Foresite Capital, Quan Capital, Hankang Capital, RA Capital Management, Logos Capital, OrbiMed
Company Description

Pinnacle Medicines is a biotechnology company pioneering the development of oral peptide therapeutics using proprietary AI and physics-based platforms.

Links
Back to HomeBack to Biotechnology DealsView Funding Announcement